A dose titration study was undertaken to determine the efficacy of
clorsulon against the adult stage of Fasciola hepatica in goats. Thirty-nine goats were experimentally infected with metacercariae of F hepatica. At 14 weeks after
infection, each goat was assigned randomly to 1 of 5 groups. Goats in groups 1 to 4 received a single
oral administration of
clorsulon at dosages of 3.5, 7, 11, and 15 mg/kg of
body weight, respectively. The fifth group of goats (control group) was infected with F hepatica, but were not treated with
clorsulon. Postmortem examination of goats at 3 weeks
after treatment revealed mean reductions in numbers of flukes of 83, 98, 99, and 100% for groups 1 to 4, respectively. Mean percentage of reduction in eggs following treatment of groups was 82, 98, 100, and 100%, respectively. The clinical effects of
clorsulon in 24 goats that were not infected with F hepatica were studied. Goats in groups 1 to 3 received a single
oral administration of
clorsulon at dosages of 7, 21, and 35 mg/kg, respectively, every other day for a total of 3 doses/goat. Group-4 goats (control group) received a vehicle placebo. Goats in group 3 were subject to postmortem examination at 14 days after dosing. Abnormal signs or lesions that could be attributed to
clorsulon were not found in any goat.